 |
|
Systemic Factors Contributory to Retinal Vein Occlusion
Michael A. McGrath, MD(Syd) BS, MRACP;
Fred Wechsler, MB,BS, FRACS, MACO;
Alex B. L. Hunyor, MB, BS, BSc(Med), DO (Syd), FRACS, MACO;
Ronald Penny, MD(Syd) BS, FRACP, FRCPA
Arch Intern Med. 1978;138(2):216-220.
Abstract
This study was undertaken in 79 patients with retinal vein occlusion to assess the different systemic mechanisms contributing to the occlusion, namely, intrinsic vessel disease and abnormalities of the blood constituents and blood viscosity.
In 55 patients older than 50 years of age, important associations were hypertension, abnormal results on glucose tolerance test, hyperlipidemia, chronic lung disease, and elevated serum IgA levels. In the 24 patients younger than 50 years of age, male incidence was high and important associations were head injuries, hyperlipidemia, and the use of estrogen-containing preparations. Hyperviscosity and cryofibrinogenemia were prominent in both groups. The pathogenesis of retinal venous occlusion is complex involving interaction between the vessel wall and blood constituents.
(Arch Intern Med 138:216-220, 1978)
Author Affiliations
From the Department of Immunology (Drs McGrath and Penny), St Vincent's Hospital, the Department of Medicine, University of New South Wales, and the Sydney Eye Hospital (Drs Hunyor and Wechsler), Sydney, Australia.
Footnotes
Accepted for publication Jan 18, 1977.
Reprint requests to Department of Immunology; St Vincent's Hospital, Victoria Street, Darlinghurst, NSW 2010, Australia (Dr Penny).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up
Pece et al.
Br J Ophthalmol 2011;95:56-68.
ABSTRACT
| FULL TEXT
Obstructive Sleep Apnea Among Patients With Retinal Vein Occlusion
Glacet-Bernard et al.
Arch Ophthalmol 2010;128:1533-1538.
ABSTRACT
| FULL TEXT
The 15-Year Cumulative Incidence of Retinal Vein Occlusion: The Beaver Dam Eye Study
Klein et al.
Arch Ophthalmol 2008;126:513-518.
ABSTRACT
| FULL TEXT
Ten-year incidence of retinal vein occlusion in an older population: the blue mountains eye study.
Cugati et al.
Arch Ophthalmol 2006;124:726-732.
ABSTRACT
| FULL TEXT
Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion
Hvarfner et al.
Br J Ophthalmol 2003;87:305-306.
ABSTRACT
| FULL TEXT
Superselective Ophthalmic Arterial Fibrinolysis with Urokinase for Recent Severe Central Retinal Venous Occlusion: Initial Experience
Vallee et al.
Radiology 2000;216:47-53.
ABSTRACT
| FULL TEXT
Central Retinal Vein Occlusion in a Patient With IgG Lambda Monoclonal Gammopathy
Enzenauer et al.
Arch Ophthalmol 1999;117:134-135.
FULL TEXT
Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion
Chen et al.
Br J Ophthalmol 1998;82:162-167.
ABSTRACT
| FULL TEXT
Activated protein C resistance in patients with central retinal vein occlusion
Larsson et al.
Br J Ophthalmol 1997;81:832-834.
ABSTRACT
| FULL TEXT
Central Retinal Vein Occlusion in a Young Child With Cyanotic Heart Disease
VanderVeen et al.
Arch Ophthalmol 1997;115:1077-1077.
ABSTRACT
Central retinal vein occlusion: what's the story?
WILLIAMSON
Br J Ophthalmol 1997;81:698-704.
FULL TEXT
Risk Factors for Central Retinal Vein Occlusion
The Eye Disease Case-Control Study Group
Arch Ophthalmol 1996;114:545-554.
ABSTRACT
Bilateral Central Retinal Vein Occlusions in a Patient With Acquired Immunodeficiency Syndrome: Clinicopathologic Correlation
Friedman and Margo
Arch Ophthalmol 1995;113:1184-1188.
ABSTRACT
Effects of Pentoxifylline on Choroidal Blood Flow in Nonproliferative Diabetic Retinopathy
Sebag et al.
ANGIOLOGY 1994;45:429-433.
ABSTRACT
Exudative Retinal Detachment Following Central and Hemicentral Retinal Vein Occlusions
Weinberg et al.
Arch Ophthalmol 1990;108:271-275.
ABSTRACT
|
